Cart
sales@molnova.com
Glycyl-L-glutamine monohydrate
CAS No. 13115-71-4
Glycyl-L-glutamine monohydrate( Glycyl-L-glutamine | Glycylglutamine )
Catalog No. M21565 CAS No. 13115-71-4
Glycyl-L-glutamine monohydrate is an inhibitory neuropeptide derived from beta-endorphin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 28 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 70 | In Stock |
|
| 1G | 103 | In Stock |
|
Biological Information
-
Product NameGlycyl-L-glutamine monohydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionGlycyl-L-glutamine monohydrate is an inhibitory neuropeptide derived from beta-endorphin.
-
DescriptionGlycyl-L-glutamine monohydrate is an inhibitory neuropeptide derived from beta-endorphin.
-
In VitroGlycyl-glutamine (Glycyl-L-glutamine) is an activate and stable glutamine-containing neuropeptide. Glycyl-glutamine (Glycyl-L-glutamine) has an advantage over free glutamine?(Gln)? as growth factors for cell culture during both autoclaving and storage.
-
In VivoGlycyl-glutamine (Glycyl-L-glutamine) (0.3, 0.6, 1.0 and 10.0 nM) can dose-dependently inhibit beta-End-(1-31)-induced hypotension in pentobarbital-anesthetized rats.
-
SynonymsGlycyl-L-glutamine | Glycylglutamine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number13115-71-4
-
Formula Weight203.2
-
Molecular FormulaC7H13N3O4
-
Purity>98% (HPLC)
-
SolubilityH2O:62.5 mg/mL (307.58 mM; Need ultrasonic)
-
SMILESNCC(=O)N[C@@H](CCC(N)=O)C(O)=O
-
Chemical Nameglycyl-L-glutamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Unal CB1 et al. Beta-endorphin-induced cardiorespiratory depression is inhibited by glycyl-L-glutamine a dipeptide derived from beta-endorphin processing.J Pharmacol Exp Ther. 1994 Nov;271(2):952-8
molnova catalog
related products
-
3',4',5',5,7-Pentame...
It is an organic compound with fomular C20H22O7.
-
Memantine
Memantine, an amantadine derivative with some dopaminergic effects, has been proposed as an antiparkinson agent and has may be used to treat moderate to severe Alzheimer's disease. It acts on the glutamatergic system by blocking NMDA receptors.
-
KALA
KALA
